(Q33680270)

28 July 2017

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia (English)

1 reference

28 July 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

Lewis B Silverman

1

1 reference

28 July 2017

Jeffrey G Supko

2

1 reference

28 July 2017

Kristen E Stevenson

3

1 reference

28 July 2017

Christina Woodward

4

1 reference

28 July 2017

Lynda M Vrooman

5

1 reference

28 July 2017

Donna S Neuberg

6

1 reference

28 July 2017

Barbara L Asselin

7

1 reference

28 July 2017

Uma H Athale

8

1 reference

28 July 2017

Luis Clavell

9

1 reference

28 July 2017

Peter D Cole

10

1 reference

28 July 2017

Kara M Kelly

11

1 reference

28 July 2017

Caroline Laverdière

12

1 reference

28 July 2017

Bruno Michon

13

1 reference

28 July 2017

Marshall Schorin

14

1 reference

28 July 2017

Cindy L Schwartz

15

1 reference

28 July 2017

Jane E O'Brien

16

1 reference

28 July 2017

Harvey J Cohen

17

1 reference

28 July 2017

Stephen E Sallan

18

1 reference

28 July 2017

language of work or name

English

0 references

publication date

10 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

115

1 reference

28 July 2017

7

1 reference

28 July 2017

1351-1353

1 reference

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826760

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia

30 October 2018

1 reference

12 December 2020

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

12 December 2020

Comparative pharmacokinetic studies of three asparaginase preparations

1 reference

12 December 2020

L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans

1 reference

12 December 2020

10.1182/BLOOD-2009-09-245951

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference